# Ultragenyx Pharmaceutical Inc.: Form 4, filed Aug 12, 2021

- Company: [Ultragenyx Pharmaceutical Inc.](/companies/rare.md) (CIK 1515673)
- Form: 4
- Filed: 2021-08-12
- Accepted by EDGAR: Aug 12, 2021, 17:11 ET
- Period: 2021-08-10
- Accession: 0001209191-21-051182
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1515673/000120919121051182/xslF345X03/doc4.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1515673/000120919121051182/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1515673/000120919121051182/xslF345X03/doc4.xml

Filed Aug 12, 2021.
Source: SEC EDGAR, the filing index for accession 0001209191-21-051182. Last ingested by Listed: Nov 3, 2026, 19:02 ET. No prices; not investment advice.